|
RNMT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.160250E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.220800E-03 |
| Normal-vs-Stage2 |
1.904270E-02 |
| Normal-vs-Stage3 |
6.560400E-04 |
| Normal-vs-Stage4 |
4.791900E-04 |
| Stage1-vs-Stage2 |
6.875800E-01 |
| Stage1-vs-Stage3 |
3.014400E-01 |
| Stage1-vs-Stage4 |
1.623820E-01 |
| Stage2-vs-Stage3 |
7.542600E-01 |
| Stage2-vs-Stage4 |
5.931800E-01 |
| Stage3-vs-Stage4 |
7.421000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.837930E-03 |
| Normal-vs-AfricanAmerican |
4.237400E-01 |
| Normal-vs-Asian |
7.381700E-03 |
| Caucasian-vs-AfricanAmerican |
1.956550E-01 |
| Caucasian-vs-Asian |
7.980400E-01 |
| AfricanAmerican-vs-Asian |
1.833620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.951000E-04 |
| Normal-vs-Female |
2.497700E-03 |
| Male-vs-Female |
5.936600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.189940E-02 |
| Normal-vs-Age(41-60Yrs) |
2.975000E-03 |
| Normal-vs-Age(61-80Yrs) |
6.825900E-04 |
| Normal-vs-Age(81-100Yrs) |
6.986100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.695600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.846800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.747000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.520600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.001800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.519800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.317500E-03 |
| Classical-VS-Follicular |
8.621900E-04 |
| Classical-VS-Other |
1.148220E-01 |
| Classical-VS-Normal |
3.092200E-02 |
| Tall-VS-Follicular |
9.965600E-01 |
| Tall-VS-Other |
6.252400E-01 |
| Tall-VS-Normal |
1.752600E-04 |
| Follicular-VS-Other |
7.189000E-01 |
| Follicular-VS-Normal |
1.753260E-04 |
| Other-VS-Normal |
2.309500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.550600E-04 |
| Normal-vs-N1 |
6.805100E-04 |
| N0-vs-N1 |
4.521600E-01 |
|
|
